About GenMark Diagnostics
GenMark Diagnostics is a company based in San Diego (United States) founded in 1993 was acquired by Roche in March 2021. GenMark Diagnostics has raised $8.56 million across 2 funding rounds from investors including Roche and SLR Investment Corp. The company has 797 employees as of December 31, 2021. GenMark Diagnostics offers products and services including ePlex System and ePlex Cartridge. GenMark Diagnostics operates in a competitive market with competitors including Inflammatix, Visby Medical, MeMed, Molbio Diagnostics and Stilla Technologies, among others.
- Headquarter San Diego, United States
- Employees 797 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Roche Diagnostics, North America
-
Annual Revenue
$171.55 M (USD)95as on Dec 31, 2020
-
Net Profit
-$18.64 M (USD)61as on Dec 31, 2020
-
EBITDA
-$11.05 M (USD)74as on Dec 31, 2020
-
Total Equity Funding
$8.56 M (USD)
in 2 rounds
-
Latest Funding Round
$65 M (USD), Debt – Conventional
Feb 08, 2019
-
Investors
Roche
& 1 more
-
Employee Count
797
as on Dec 31, 2021
-
Acquired by
Roche
(Mar 15, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenMark Diagnostics
GenMark Diagnostics offers a comprehensive portfolio of products and services, including ePlex System and ePlex Cartridge.
Automates nucleic acid testing for pathogen detection.
Enables single-use molecular assays for diagnostics.
People of GenMark Diagnostics
Unlock access to complete
Software Development Team
35 people
Product Management Team
21 people
Senior Team
11 people
Leadership Team
9 people
Sales and Marketing
5 people
Scientist Team
5 people
Data Analysis and Operations Team
5 people
Research Team
5 people
Unlock access to complete
Funding Insights of GenMark Diagnostics
GenMark Diagnostics has successfully raised a total of $8.56M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $65 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GenMark Diagnostics
GenMark Diagnostics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Roche and SLR Investment Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Debt and equity investments are offered by the firm.
|
Locked | Locked | Locked | |
|
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
Locked | Locked | Locked |
Investor details for GenMark Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenMark Diagnostics
Investment portfolio details for GenMark Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GenMark Diagnostics
Detailed financials for GenMark Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genmark Diagnostics Comparisons
Peer comparison for GenMark Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenMark Diagnostics
GenMark Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Visby Medical, MeMed, Molbio Diagnostics and Stilla Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| Locked | Locked | Locked |
Digital PCR solutions for research are developed and analyzed.
|
Detailed competitors of GenMark Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genmark Diagnostics
Complete news archive for GenMark Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenMark Diagnostics
GenMark Diagnostics was founded in 1993 and raised its 1st funding round 16 years after it was founded.
GenMark Diagnostics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
GenMark Diagnostics is a funded company, having raised a total of $8.56M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at GenMark Diagnostics is 797.
Annual revenue of GenMark Diagnostics is $171.55M as on Dec 31, 2020.
Founded in 1993 in San Diego, United States, multiplexed molecular diagnostics are supported through instruments and test panels. The ePlex System incorporates digital microfluidics for PCR-based assays, with results obtained in under 90 minutes. Disposable cartridges in the XT-8 system enable analyte measurement via electrochemical sensors. Test panels are developed for CNS, GI, respiratory, and hepatic infections, along with genetic disorders.
GenMark Diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
GenMark Diagnostics offers ePlex System and ePlex Cartridge.
GenMark Diagnostics has 2 investors. Key investors include Roche, and SLR Investment Corp.